About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Abbott India Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
500488
ISIN Demat
INE358A01014
Book Value
1992.14
NSE Code
ABBOTINDIA
Dividend Yield %
1.36
Market Cap
738785.11
P/E
52.23
EPS
665.64
Face Value
10
BSE
NSE
01-Jul-2025 14:25
BSE
NSE
NSE F & O
01-Jul-2025 14:19
BSE
NSE
NSE F & O
Last Price
34767.45
Net Change
-870
% Change
-2.44%
Prev.Close
35637.45
Open
35798.80
High
35799.90
Low
34740.00
Volume
215
Last Price
34765.00
Net Change
-905
% Change
-2.54%
Prev.Close
35670.00
Open
35675.00
High
35800.00
Low
34715.00
Volume
10952
Value
7475001.75
Best Buy
34706.35
Best Sell
34803.70
Best Quantity
2
Sell Quantity
2
Today's Range
35799.90
52-Week High
35829.60
52-Week Low
25260.20
Value
380746280
Best Buy
34755.00
Best Sell
34795.00
Best Quantity
3
Sell Quantity
4
Today's Range
35800.00
52-Week High
37000.00
52-Week Low
25325.00
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
2
Price
34706.35
Quantity
2
Price
34803.70
Best Bid
Best Offer
Quantity
3
Price
34755.00
Quantity
4
Price
34795.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
04-Aug-22
10-Aug-22
Dividend
4750 %
25-Jul-25
Company News
26-06-2025
Abbott India informs abou...
19-06-2025
Abbott, MSD Pharmaceutica...
16-04-2025
Abbott India informs abou...
16-04-2025
Abbott India informs abou...
10-04-2025
Abbott India informs abou...
06-03-2025
Abbott India informs abou...
27-02-2025
Abbott India informs abou...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.